Jaks and Stats as therapeutic targets

Annals of the Rheumatic Diseases

Volumn 59, Issue SUPPL. 1, 2000, Pages

  O'Shea, J J ^a,b   Visconti, R ^a,b   Cheng, T P ^a,b   Gadina, M ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b National Institute of Arthritis Musculoskeletal and Skin Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; ENZYME INHIBITOR; IMMUNOSUPPRESSIVE AGENT; JANUS KINASE; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; STAT PROTEIN; TRANSCRIPTION FACTOR; TYRPHOSTIN; UNCLASSIFIED DRUG;

CONFERENCE PAPER; DRUG TARGETING; ENZYME ACTIVATION; GENE MUTATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

ANIMALS; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MICE; PROTEIN-TYROSINE KINASES; TRANS-ACTIVATORS;

EID: 0033758397     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (61)

1. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins
2. Signaling through the hematopoietic cytokine receptors
3. Jaks and STATs: Biological implications
4. Mutation of Jak3 in a patient with SCID: Essential role of Jak3 in lymphoid development
5. Mutations of Jak-3 gene in patients with autosomal severe combined immune deficiency (SCID)
6. Defective lymphoid development in mice lacking Jak3
7. Defects in B lymphocyte maturation and T lymphocyte activation in mice lacking Jak3
8. Developmental defects of lymphoid cells in Jak3 kinase-deficient mice
9. T cell development and activation in Jak3-deficient mice
10. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency
11. IL-15 receptor maintains lymphoid homeostasis by supporting lymphocyte homing and proliferation
12. Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice
13. Disruption of the Jak1 gene demonstrates obligatory and nonredundant roles of the Jaks in cytokine-induced biologic responses
14. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis
15. Jak2 is essential for signaling through a variety of cytokine receptors
16. Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia
17. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
18. Fusion of the ets transcription factor TEL to Jak2 results in constitutive Jak-Stat signaling
19. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
20. Complex effects of naturally occurring mutations in the JAK3 pseudokinase domain: Evidence for interactions between the kinase and pseudokinase domains
21. Structural and functional basis for JAK3-deficient severe combined immunodeficiency
22. Regulation of the Jak2 tyrosine kinase by its pseudokinase domain
23. The amino terminus of JAK3 is necessary and sufficient for binding to the common gamma chain and confers the ability to transmit interleukin 2-mediated signals
24. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: Mapping of the Jak3-receptor interaction domain
25. Definition of the interferon-alpha receptor-binding domain on the TYK2 kinase
26. Specific contribution of tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1
27. The use of antibodies against the IL-2 receptor in transplantation
28. Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia
29. Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
30. Crystal structure of an angiogenesis inhibitor bound to the FGF receptor tyrosine kinase domain
31. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor
32. Tyrphostin B42 inhibits IL-12-induced tyrosine phosphorylation and activation of Janus kinase-2 and prevents experimental allergic encephalomyelitis
33. Tyrphostin AG-490 inhibits cytokine-mediated JAK3/STAT5a/b signal transduction and cellular proliferation of antigen-activated human T cells
34. JAK3, STAT, and MAPK signaling pathways as novel molecular targets for the tyrphostin AG-490 regulation of IL-2-mediated T cell response
35. The immunosuppressive metabolite of leflunomide, A77 1726, affects murine T cells through two biochemical mechanisms
36. Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production
37. Structure-based design of specific inhibitors of Janus kinase 3 as apoptosis-inducing antileukemic agents
38. Targeting Janus kinase 3 in mast cells prevents immediate hypersensitivity reactions and anaphylaxis
39. In vivo toxicity and pharmacokinetic features of the janus kinase 3 inhibitor WHI-P131 [4-(4'hydroxyphenyl)-amino-6,7- dimethoxy-quinazoline]
40. A specific inhibitor of janus kinase-3 increases survival in a transgenic mouse model of amyotrophic lateral sclerosis
41. Jaks, STATs, cytokine signal transduction, and immunoregulation: Are we there yet?
42. STATs as mediators of cytokine-induced responses
43. Crystal structure of a tyrosine phosphorylated STAT-1 dimer bound to DNA
44. Three-dimensional structure of the Stat3beta homodimer bound to DNA
45. Structure of the amino-terminal protein interaction domain of STAT-4
46. The mitogen-activated protein (MAP) kinase p38 and its upstream activator MAP kinase kinase 6 are involved in the activation of signal transducer and activator of transcription by hyperosmolarity
47. Stress activated protein kinase p38 is involved in IL-6 induced transcriptional activation of STAT3
48. Stress-induced phosphorylation of STAT1 at Ser727 requires p38 mitogen- activated protein kinase whereas IFN-gamma uses a different signaling pathway
49. p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons
50. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease
51. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway
52. Demonstration of an interferon gamma-dependent tumor surveillance system in immunocompetent mice
53. Targeted disruption of the mouse Stat3 gene leads to early embryonic lethality
54. Enhanced Th1 activity and development of chronic enterocolitis in mice devoid of Stat3 in macrophages and neutrophils
55. Impaired IL-12 responses and enhanced development of Th2 cells in Stat4-deficient mice
56. Requirement for Stat4 in interleukin-12-mediated responses of natural killer and T cells
57. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells
58. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
59. Essential role of Stat6 in IL-4 signalling
60. Stat5a is mandatory for adult mammary gland development and lactogenesis
61. Requirement of STAT5b for sexual dimorphism of body growth rates and liver gene expression